By: Ethan Perez, UCI Beall Applied Innovation
Photo by: UCI Beall Applied Innovation
The UCI startup is developing a better imaging platform to aid in the diagnosis, management and understanding of skin conditions.
Skin cancer and other skin conditions afflict a large portion of the population. According to the American Academy of Dermatology Association, skin cancer alone is the most common cancer in the United States, with an estimated one-in-five Americans developing skin cancer in their lifetime.
To diagnose and treat skin cancer and other skin conditions, dermatologists use a number of tools and techniques at their disposal to give their patients the best outcomes possible.
UCI startup InfraDerm is developing a noninvasive imaging platform to monitor the effects of skin therapies, understand the biology that underlies skin diseases and skin conditions, and aid in the diagnosis of skin diseases.
Read full article on UCI Beall Applied Innovation.